Answers are grounded in this paper and cite their sources.
Traditional Chinese non-pharmacological therapies have shown potential in reducing analgesic use in low back pain (LBP) management. However, few studies have examined the performance of the most commonly used generic preference-based measure, the EQ-5D-5L, for traditional Chinese non-pharmacological therapies. This study aimed to assess its performance among patients with LBP receiving such therapies in China. The EQ-5D-5L, the Oswestry Disability Index (ODI) and the Quebec Back Pain Disability Scale (QBPDS) were collected before and after an episode of traditional Chinese non-pharmacological therapies. EQ-5D-5L’s ceiling and flooring effects, convergent validity, known-group validity (grouped by gender, age and pain level) and informativity (Shannon [H’] and Shannon evenness [J’] indices) were assessed at baseline. After treatment, individuals who completed the assessment were categorized into 4 subgroups against the change of ODI ( n = 150). EQ-5D-5L’s responsiveness was assessed using effect size (ES), standardized response mean (SRM) and Guyatt’s Responsiveness Index (GRI). A total of 350 individuals were recruited at baseline (average age 49.51 ± 16.17 years, 57.4% female), among which 150 individuals completed the EQ-5D-5L after treatment. EQ-5D-5L showed no ceiling or floor effects. Regarding the convergent validity, correlation coefficients between EQ dimensions and ODI ranged from 0.60 to 0.81, 0.48 to 0.82 for QBPDS. The hypothesises of known-group analysis was confirmed among pre-defined groups. Informativity for each EQ-5D-5L dimension were excellent (H’,1.93 to 2.09, J’, 0.83 to 0.90). The responsiveness for each improvement subgroup was good (ES: 1.65–6.49, SRM: 1.76–6.40, GRI: 1.91 to 6.18). Our study provided evidence that EQ-5D-5L may be a suitable health-related quality of life measure for LBP patients receiving traditional Chinese non-pharmacological therapies and indicated that it could be useful for economic evaluations in this context.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: